Control of serum phosphorus levels and increase in and maintenance of iron stores, leading to reduction in IV iron use in patients with chronic kidney disease on dialysis
Interaction
Brite
USP drug classification [BR:br08302]
Electrolytes/Minerals/Metals/Vitamins
Phosphate Binders
Ferric citrate
D10705 Ferric citrate (USAN)
Drug groups [BR:br08330]
Blood modifier agent
DG01694 Iron preparation
DG01859 Ferric citrate
D10705 Ferric citrate
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10705
Drug groups [BR:br08330]
Blood modifier agent
DG01694 Iron preparation
DG01859 Ferric citrate